Evidence map›Paper›PMID 32230861›Full record

ArticleInternational journal of molecular sciences2020

Anti-Inflammatory and Anti-Migratory Activities of Isoquinoline-1-Carboxamide Derivatives in LPS-Treated BV2 Microglial Cells via Inhibition of MAPKs/NF-κB Pathway.

Ha Thi Thu Do, Bich Phuong Bui, Seongrak Sim, Jae-Kyung Jung, Heesoon Lee, Jungsook Cho

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Anti-Neuroinflammatory Potential of aAntioxidants (Basel, Switzerland) · 2023
    Article
  6. Effects of Apamin on MPPInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Mitigating Effect ofMolecules (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ha Thi Thu DoCollege of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, Korea.
Bich Phuong BuiCollege of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, Korea.
Seongrak SimCollege of Pharmacy, Chungbuk National University, Osong, Cheongju 28160, Korea.
Jae-Kyung JungCollege of Pharmacy, Chungbuk National University, Osong, Cheongju 28160, Korea.ORCID 0000-0002-0490-9663
Heesoon LeeCollege of Pharmacy, Chungbuk National University, Osong, Cheongju 28160, Korea.
Jungsook ChoCollege of Pharmacy, Dongguk University-Seoul, Goyang, Gyeonggi 10326, Korea.

Funding

National Research Foundation of Korea NRF-2018R1A5A2023127 and NRF-2019R1F1A1057601
6 · The paper itself

Abstract

Eleven novel isoquinoline-1-carboxamides (HSR1101~1111) were synthesized and evaluated for their effects on lipopolysaccharide (LPS)-induced production of pro-inflammatory mediators and cell migration in BV2 microglial cells. Three compounds (HSR1101~1103) exhibited the most potent suppression of LPS-induced pro-inflammatory mediators, including interleukin (IL)-6, tumor necrosis factor-alpha, and nitric oxide (NO), without significant cytotoxicity. Among them, only

Indexed as

AnimalsAnti-Inflammatory AgentsCell MovementCyclooxygenase 2CytokinesInflammation MediatorsInhibitory Concentration 50Interleukin-10Interleukin-6IsoquinolinesLipopolysaccharidesMAP Kinase Signaling SystemMiceMicrogliaMitogen-Activated Protein KinasesNeurodegenerative DiseasesAnti-Inflammatory AgentsCyclooxygenase 2CytokinesInflammation MediatorsInterleukin-10Interleukin-6IsoquinolinesLipopolysaccharidesMitogen-Activated Protein KinasesNF-kappa BNitric OxideNitric Oxide Synthase Type IITumor Necrosis Factor-alphaBV2 microglial cellscell migrationintracellular signalingisoquinoline-1-carboxamidemitogen-activated protein kinases (MAPKs)neurodegenerationneuroinflammationnuclear factor-kappa B (NF-κB)

Identifiers

PMID32230861
PMCPMC7177615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.